JPS5683483A - Thiazolidine compound - Google Patents

Thiazolidine compound

Info

Publication number
JPS5683483A
JPS5683483A JP16197779A JP16197779A JPS5683483A JP S5683483 A JPS5683483 A JP S5683483A JP 16197779 A JP16197779 A JP 16197779A JP 16197779 A JP16197779 A JP 16197779A JP S5683483 A JPS5683483 A JP S5683483A
Authority
JP
Japan
Prior art keywords
formula
compound
group
integer
thiazolidine compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP16197779A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0140030B2 (enExample
Inventor
Masayuki Ooya
Tadashi Iso
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Santen Pharmaceutical Co Ltd
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Priority to JP16197779A priority Critical patent/JPS5683483A/ja
Priority to AT80107869T priority patent/ATE16183T1/de
Priority to EP80107869A priority patent/EP0031104B1/en
Priority to DE8080107869T priority patent/DE3071202D1/de
Publication of JPS5683483A publication Critical patent/JPS5683483A/ja
Priority to US06/329,296 priority patent/US4499102A/en
Publication of JPH0140030B2 publication Critical patent/JPH0140030B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP16197779A 1979-12-13 1979-12-13 Thiazolidine compound Granted JPS5683483A (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP16197779A JPS5683483A (en) 1979-12-13 1979-12-13 Thiazolidine compound
AT80107869T ATE16183T1 (de) 1979-12-13 1980-12-12 Thiazolidin-verbindungen, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
EP80107869A EP0031104B1 (en) 1979-12-13 1980-12-12 Thiazolidine compounds, processes for their preparation and pharmaceutical compositions containing them
DE8080107869T DE3071202D1 (en) 1979-12-13 1980-12-12 Thiazolidine compounds, processes for their preparation and pharmaceutical compositions containing them
US06/329,296 US4499102A (en) 1979-12-13 1981-12-10 Thiazolidine and pyrrolidine compounds and pharmaceutical compositions containing them

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP16197779A JPS5683483A (en) 1979-12-13 1979-12-13 Thiazolidine compound

Publications (2)

Publication Number Publication Date
JPS5683483A true JPS5683483A (en) 1981-07-08
JPH0140030B2 JPH0140030B2 (enExample) 1989-08-24

Family

ID=15745672

Family Applications (1)

Application Number Title Priority Date Filing Date
JP16197779A Granted JPS5683483A (en) 1979-12-13 1979-12-13 Thiazolidine compound

Country Status (4)

Country Link
EP (1) EP0031104B1 (enExample)
JP (1) JPS5683483A (enExample)
AT (1) ATE16183T1 (enExample)
DE (1) DE3071202D1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5692279A (en) * 1979-12-25 1981-07-25 Santen Pharmaceut Co Ltd Thiazolidine derivative

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR75019B (enExample) * 1980-09-17 1984-07-12 Univ Miami
EP0059966B1 (en) * 1981-03-09 1986-08-13 Merck & Co. Inc. Substituted thiazolidine carboxylic acid analogs and derivatives as antihypertensives
EP0175266B1 (en) * 1984-09-12 1996-03-20 Rhone-Poulenc Rorer Pharmaceuticals Inc. Antihypertensive derivatives
ATE256699T1 (de) * 1997-05-30 2004-01-15 Celltech Therapeutics Ltd Entzündungshemmende tyrosin-derivate
GB9713087D0 (en) * 1997-06-20 1997-08-27 Celltech Therapeutics Ltd Chemical compounds
US6329372B1 (en) 1998-01-27 2001-12-11 Celltech Therapeutics Limited Phenylalanine derivatives
WO1999043642A1 (en) 1998-02-26 1999-09-02 Celltech Therapeutics Limited Phenylalanine derivatives as inhibitors of alpha4 integrins
GB9805655D0 (en) 1998-03-16 1998-05-13 Celltech Therapeutics Ltd Chemical compounds
US6521626B1 (en) 1998-03-24 2003-02-18 Celltech R&D Limited Thiocarboxamide derivatives
GB9811159D0 (en) 1998-05-22 1998-07-22 Celltech Therapeutics Ltd Chemical compounds
GB9811969D0 (en) 1998-06-03 1998-07-29 Celltech Therapeutics Ltd Chemical compounds
GB9814414D0 (en) 1998-07-03 1998-09-02 Celltech Therapeutics Ltd Chemical compounds
GB9821061D0 (en) 1998-09-28 1998-11-18 Celltech Therapeutics Ltd Chemical compounds
GB9821222D0 (en) 1998-09-30 1998-11-25 Celltech Therapeutics Ltd Chemical compounds
GB9825652D0 (en) 1998-11-23 1999-01-13 Celltech Therapeutics Ltd Chemical compounds
GB9826174D0 (en) 1998-11-30 1999-01-20 Celltech Therapeutics Ltd Chemical compounds
US6518283B1 (en) 1999-05-28 2003-02-11 Celltech R&D Limited Squaric acid derivatives
US6534513B1 (en) 1999-09-29 2003-03-18 Celltech R&D Limited Phenylalkanoic acid derivatives
US6455539B2 (en) 1999-12-23 2002-09-24 Celltech R&D Limited Squaric acid derivates
ATE375330T1 (de) 2000-04-17 2007-10-15 Ucb Pharma Sa Enamin-derivate als zell-adhäsionsmoleküle
US6545013B2 (en) 2000-05-30 2003-04-08 Celltech R&D Limited 2,7-naphthyridine derivatives
US6403608B1 (en) 2000-05-30 2002-06-11 Celltech R&D, Ltd. 3-Substituted isoquinolin-1-yl derivatives
WO2002004426A1 (en) 2000-07-07 2002-01-17 Celltech R & D Limited Squaric acid derivatives containing a bicyclic heteroaromatic ring as integrin antagonists
AU2001275724A1 (en) 2000-08-02 2002-02-13 Celltech R&D Limited 3-substituted isoquinolin-1-yl derivatives

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5382778A (en) * 1976-12-03 1978-07-21 Squibb & Sons Inc Thiazolidinecarboxylate derivative and related compounds thereof process for preparing same and application thereof
JPS6048511A (ja) * 1983-08-26 1985-03-16 Hitachi Kiden Kogyo Ltd 移動体の誘導ならびに通信装置
JPS6213350A (ja) * 1985-07-12 1987-01-22 Hitachi Ltd マルチノズルインクジエツトプリンタ

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH515720A (de) * 1968-11-20 1971-11-30 Eprova Ag Neue Röntgenkontrastmittel und Verfahren zu ihrer Herstellung
US4052511A (en) * 1976-02-13 1977-10-04 E. R. Squibb & Sons, Inc. Carboxyacylproline derivatives
AU509899B2 (en) * 1976-02-13 1980-05-29 E.R. Squibb & Sons, Inc. Proline derivatives and related compounds
US4154937A (en) * 1977-02-11 1979-05-15 E. R. Squibb & Sons, Inc. Hydroxycarbamoylalkylacylpipecolic acid compounds
FR2395998A1 (fr) * 1977-06-29 1979-01-26 Yoshitomi Pharmaceutical Nouveaux derives de la thiazolidine et leur application dans le traitement de l'hypertension
IT7851510A0 (it) * 1977-10-28 1978-10-16 Sandoz Ag Ammidi di amminoacidi ciclici loro preparazione e loro applicazione quali medicamenti
FR2412537A1 (fr) * 1977-12-22 1979-07-20 Science Union & Cie Nouveaux thiobutyramides substitues, leurs procedes d'obtention et leur application pharmaceutique
JPS559058A (en) * 1978-07-06 1980-01-22 Dainippon Pharmaceut Co Ltd 1-(3-mercapto-2-methylpropanoyl)prolyl amino acid derivative
JPS5531022A (en) * 1978-08-24 1980-03-05 Yoshitomi Pharmaceut Ind Ltd Hydroxamic acid derivative and its preparation
US4483861A (en) * 1978-10-31 1984-11-20 Santen Pharmaceutical Co., Ltd. Antihypertensive sulfur-containing compounds
IL58849A (en) * 1978-12-11 1983-03-31 Merck & Co Inc Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
US4347371A (en) * 1978-12-30 1982-08-31 Santen Pharmaceutical Co., Ltd. Disulfide compounds
JPS56139455A (en) * 1980-04-02 1981-10-30 Santen Pharmaceut Co Ltd Sulfur-containing acylaminoacid

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5382778A (en) * 1976-12-03 1978-07-21 Squibb & Sons Inc Thiazolidinecarboxylate derivative and related compounds thereof process for preparing same and application thereof
JPS6048511A (ja) * 1983-08-26 1985-03-16 Hitachi Kiden Kogyo Ltd 移動体の誘導ならびに通信装置
JPS6213350A (ja) * 1985-07-12 1987-01-22 Hitachi Ltd マルチノズルインクジエツトプリンタ

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5692279A (en) * 1979-12-25 1981-07-25 Santen Pharmaceut Co Ltd Thiazolidine derivative

Also Published As

Publication number Publication date
EP0031104A1 (en) 1981-07-01
JPH0140030B2 (enExample) 1989-08-24
DE3071202D1 (en) 1985-11-28
EP0031104B1 (en) 1985-10-23
ATE16183T1 (de) 1985-11-15

Similar Documents

Publication Publication Date Title
JPS5683483A (en) Thiazolidine compound
JPS5559140A (en) 3,5-dihydroxypentanoic alkyl ester derivative, its preparation and remedy for hyperlipemia containing the same as the effective component
EP0033617A3 (en) Thiazolidine derivatives and their production and medicinal compositions containing them
JPS5692893A (en) Novel cephem compound, its preparation, and preventive and remedy for bacteriosis containing said compound as effective component
JPS57136579A (en) Thiazolylurea derivative, its preparation, and pharmaceutical composition containing the same
JPS5535096A (en) 3-cephem compound, its salt, their preparation, and preventive and remedy for microbism comprising thema active constituent
JPS574977A (en) 2-guanidinothiazole derivative
JPS6452765A (en) Thiazolidine derivative
JPS57200335A (en) N-substituted derivative of valiolamine, its preparation and use
JPS559060A (en) Thia(oxa)zolidinecarboxylic acid derivative and its prepatation
JPS572297A (en) Moranoline derivative and its preparation
JPS5758677A (en) Germanium compound of thiazolidine derivative and its preparation
IE901299L (en) Novel compounds
JPS5481260A (en) 2-4-(3-methyl-2-thienyl)phenyl propionic acid, its nontoxic salt and antiphlogistics, analgesics, and antirheumatics containing them
JPS5536411A (en) Benzylpenicillin derivative and their preparation
JPS5742664A (en) Alpha-substituted ureidophenylacetic acid derivative
JPS56161395A (en) 7-substituted ureido-3-cephem-4-carboxylic acid derivative, its preparation and preventing agent and remedy for microbism containing the same as active constituent
JPS5750980A (en) Tetrazole derivative
JPS56104876A (en) Thiazolidine derivative
JPS579784A (en) Production of penem-3-carboxylic derivative
JPS54154754A (en) Beta-lactone derivative of antiesterase active substance delta-hydroxymicolic acid and its preparation
JPS55124757A (en) Sulfur-containing compound
JPS5524139A (en) Optically active intermediate and its preparation
JPS54128592A (en) Cephalosporin derivatives and its preparation
JPS5511511A (en) Alpha-bromo(p-acyloxyphenyl)acetic acid